CITIUS ONCOLOGY, INC. - CTOR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$6.853M
QoQ value delta ($000)
-$10.11M (-59.6%)
Implied price effect (QoQ)
-50.79%
Shares
Total shares
6,861,200
QoQ shares delta
-1,495,959 (-17.9%)
Total shares held by funds (by quarter)

Market chart (CTOR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 5,584 5,584,080 0.07%
VANGUARD GROUP INC 596 596,997 0.0%
GEODE CAPITAL MANAGEMENT, LLC 220 220,047 0.0%
OMERS ADMINISTRATION Corp 104 104,500 0.0%
IFP Advisors, Inc 87 87,424 0.0%
XTX Topco Ltd 73 73,992 0.0%
NORTHERN TRUST CORP 45 45,746 0.0%
STATE STREET CORP 42 42,900 0.0%
TWO SIGMA INVESTMENTS, LP 23 23,515 0.0%
BlackRock, Inc. 22 22,344 0.0%
UBS Group AG 21 21,464 0.0%
TWO SIGMA SECURITIES, LLC 13 13,360 0.0%
OSAIC HOLDINGS, INC. 11 11,425 0.0%
Arkadios Wealth Advisors 11 11,666 0.0%
Versant Capital Management, Inc 1 1,500 0.0%
BANK OF AMERICA CORP /DE/ 0 214 0.0%
ROYAL BANK OF CANADA 0 23 0.0%
Farther Finance Advisors, LLC 0 3 0.0%